Vinod Chandran, MBBS, MD, DM is an Assistant Professor of Medicine and Rheumatology, a Clinician-Scientist at the University of Toronto, and a staff physician at the University Health Network and Mount Sinai Hospitals, Toronto, Ontario, Canada. He is a member of the Centre for Prognosis Studies in the Rheumatic Diseases and co-Director of the Psoriatic Arthritis Program, University Health Network. Dr. Chandran’s research interests lie in the genetic and molecular epidemiology of psoriasis and psoriatic arthritis, especially with respect to prognosis. He has more than 50 peer-reviewed publications, more than 20 chapters and invited publications and more than 150 published abstracts. Important contributions to psoriatic arthritis include the recognition that the disease is highly heritable. Dr. Chandran and colleagues demonstrated that classification criteria for psoriatic arthritis are valid in early disease and that tools used for assessing psoriatic disease have moderate inter-rater reliability. He and his colleagues have also identified risk factors for axial arthritis in psoriatic arthritis as well as biomarkers that distinguish psoriatic arthritis from patients with psoriasis alone. He is a recipient of a Canadian Institutes of Health Research fellowship, Metro A. Ogryzlo International Fellowship, Post-Doctoral Fellowship Awards from the Canadian Arthritis Network and the Arthritis and Autoimmunity Research Centre Foundation as well as a Krembil Psoriatic Arthritis Fellowship. He is also a recipient of a Future Leaders in Rheumatology Training award. He is a reviewer for 18 international journals and an associate faculty member of Faculty of 1000 Medicine. He is also a member of the steering committee of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis. His work is supported by research grants from the Canadian Institutes of Health Research, the Arthritis Society, Abbvie Canada, and the Krembil Foundation.
Biography Updated on 16 April 2013